![](/img/cover-not-exists.png)
3086 A Phase 1b study to evaluate the safety and antitumor activity of MEDI4736 in combination with tremelimumab in patients with advanced NSCLC
Goldberg, S.B., Balmanoukian, A., Chaft, J., Rizvi, N., Sanborn, R.E., Rebelatto, M.C., Narwal, R., Robbins, P.B., Gu, Y., Karakunnel, J.J., Antonia, S.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31727-0
Date:
September, 2015
File:
PDF, 59 KB
english, 2015